HAVE CONFIDENCE
AT EVERY TURN
Clinical endpoint data collection, predictive analytics, and real world evidence – draw on our science, technological, global experience and credibility, learned over 15k trials, to power your clinical development with certainty, quality and speed
4.3M+
Patients Enrolled
230K
Sites Supported
600+
Drug Approvals
15K
Trials Managed
moving ahead requires a sure path forward
Every detail matters. We spot risks before they become problems and help you avoid costly delays through our latest solution Trial Oversight.
NEWS & EVENTS
LATEST NEWS
August 5, 2019
ERT Leader Recognized by PharmaVoice for Delivering Innovation in Clinical Trial Imaging
Timothy Kulbago, Vice President, Imaging has been named one of the 100 most inspiring individuals in the life-sciences industry by PharmaVoice.
July 31, 2019
ERT Recognized for Innovation in Health Technology: Pittsburgh Technology Council names ERT to Tech 50
ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has been named one of the 50 most successful and innovative technology companies of the Pittsburgh region by the Pittsburgh Technology Council.
July 10, 2019
Patient-Reported Outcome (PRO) Data in Oncology Trials – Part 1: Regulations
In this first of a 2-part series on the importance of PRO data in oncology drug development, we review the latest regulatory guidances recommending the use of PROs in oncology trials.